Inari Medical Inc (NARI)
41.20
+0.52
(+1.28%)
USD |
NASDAQ |
Sep 27, 16:00
41.14
-0.06
(-0.16%)
After-Hours: 20:00
Inari Medical SG&A Expense (TTM): 406.98M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 406.98M |
March 31, 2024 | 378.42M |
December 31, 2023 | 361.06M |
September 30, 2023 | 339.69M |
June 30, 2023 | 327.24M |
March 31, 2023 | 314.81M |
December 31, 2022 | 292.84M |
September 30, 2022 | 267.19M |
June 30, 2022 | 247.46M |
March 31, 2022 | 217.20M |
Date | Value |
---|---|
December 31, 2021 | 190.36M |
September 30, 2021 | 167.29M |
June 30, 2021 | 134.27M |
March 31, 2021 | 110.25M |
December 31, 2020 | 89.75M |
September 30, 2020 | 72.22M |
June 30, 2020 | 59.24M |
March 31, 2020 | 48.16M |
December 31, 2019 | 37.20M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
37.20M
Minimum
Dec 2019
406.98M
Maximum
Jun 2024
213.77M
Average
217.20M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
Nevro Corp | 326.85M |
Inspire Medical Systems Inc | 495.06M |
Axonics Inc | 264.58M |
Electromed Inc | 34.49M |
Myomo Inc | 20.12M |